Skip to content

Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes

Community, Health Center, and Academic Medicine Partnership Project (CHAMPP)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00379652
Acronym
CHAMPP
Enrollment
1204
Registered
2006-09-22
Start date
2009-10-31
Completion date
2010-05-31
Last updated
2023-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitis, Hypertension

Keywords

Community Health Centers, Diabetes, Blood Pressure, High

Brief summary

Hypertension and diabetes are among the most common chronic diseases in the United States. Racial and ethnic minority groups are more at risk for these diseases than the Caucasian population. This study will attempt to identify factors that contribute to racial and ethnic differences in hypertension and diabetes care among minority patients of community health centers (CHCs). This information will be used to design and implement programs to improve quality of care in these communities.

Detailed description

Hypertension and diabetes are the primary contributors to today's high rates of heart disease and stroke, which are the first and third leading causes of death in the United States, respectively. African Americans and Hispanics have a higher risk of developing hypertension and diabetes than do Caucasians. They are also less likely to know that they have high blood pressure, are more prone to organ damage, and are more likely to die as a result of these chronic conditions. A significant number of African Americans and Hispanics are uninsured and receive care through publicly supported CHCs. It is important to identify factors that contribute to healthcare differences among the lower income, uninsured, and minority populations that are typically served by CHCs. In this study, a collaborative partnership will be developed between CHCs, health service research organizations, and academic researchers. The goal of the study is to examine the barriers that minority CHC patients face in receiving appropriate hypertension and diabetes care. This study will develop a collaborative partnership between various health organizations and seven CHCs located in Boston neighborhoods that have a large percentage of African American and Hispanic residents. Researchers will conduct focus groups with CHC patients who are receiving care for hypertension or diabetes. CHC staff members will be interviewed to collect information regarding the relationship between CHC organizational structure and disparities in heart disease risk factors among minority patients with hypertension or diabetes. Researchers will then develop, implement, and evaluate a patient- and CHC-focused intervention aimed at reducing the cardiovascular risks of minority patients at four CHCs in Boston.

Interventions

BEHAVIORALMedical Practice Improvement

The details for the medical practice improvement intervention will be decided at a later date.

BEHAVIORALPatient Education and Support

The details for the patient education and support intervention will be decided at a later date.

OTHERCombination Intervention to Include Medical Practice Improvement and Patient Education and Support

The details for this combination intervention will be decided at a later date.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Harvard Medical School (HMS and HSDM)
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diabetes * Hypertension, as diagnosed by the average of two or more blood pressure measurements taken during two or more study visits following an initial screening * Race is 'Black' or ethnicity is 'Hispanic' * Patient at participating Community Health Center

Design outcomes

Primary

MeasureTime frame
Potential outcomes for the future intervention include systolic blood pressure, diastolic blood pressure, and hemoglobin A1cMeasured from June to August 2008

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026